After we have been confronted with the growing, unmet need of our clients to outsource in a greener way for a couple of years, DuDeChem was created in order to solve this problem and now started its operations.
Jost will challenge in her keynote on 06/02 the need to still consider the harms created by chemical products and the manufacturing thereof as a necessary pre-condition for the benefits created – and describe why they are already a threat to our competitiveness and to our wealth.
As the winter semester draws to a close, the first data analytics course for chemists at a German university has now completed its pilot run. DexLeChem engineer Tino lectured to 30 master and PhD students at the TU Berlin. Within 5 seconds, the course was completely booked!
Boehringer Ingelheim scouted globally for a technology provider in order to support their in-house process development and manufacturing departments. They chose DexLeChem due to our outstanding expertise in STEM & sustainability.
"The opportunities of digitalization seem to be infinite for an industry which has not been disrupted so far – but so are the threats." (Report German Startups Association, 2018).
Sonja (picture center), CEO DexLeChem and event initiator
DexLeChem has successfully worked for another global top pharma player, AstraZeneca which has given an outstanding testimonial about the development work DexLeChem performed.
The 35 jury members of the SME instrument program decide about an annual budget of 500 m € which is granted to hightech startups and other SME in their growth phase.
The commercialization of water-based catalysis (WO 2014/135605 A1) and the reduction of nitro derivatives (WO 2014/037444 A1) succeed DexLeChem by competitive production processes in the production of pharmaceuticals and other fine chemicals.
Very recently, another catalyst re-using project was accomplished for the world’s largest CMO and once again, the experienced industrial experts gave outstanding testimonials about DexLeChem’s high level of innovative solutions and its strong focus on upscalability for production.
The digitalisation in the chemical industry and its business impact is the main topic on the panel and will be discussed by DexLeChem CEO Jost and BASF CTO Brudermüller during the digital conference of the German Government.
At the Global Business Summit, which takes place March 20th-22nd in Amsterdam, CEO Jost reports about the benefits of using water as a solvent in the manufacturing of fine chemicals.
As one of the world's leading suppliers of ingredients to the food and pharmaceutical industry, the renowned catalysis expert DSM Nutritional Products AG (J. Schütz, J. Medlock, A. Puhl) is satisfied about the successful collaboration with DexLeChem (S. Jost):
Under the patronage of Germany’s federal minister Schwesig, foundress and CEO Jost gives a talk at FIM Business Day 2016 about DexLeChem’s successful market entry into the chemical-pharmaceutical industry.
The U.S. patent office has recently granted DexLeChem the patent US 9284258 B2 in its full scope. The European patent office has already communicated its intention to grant the patent as well.
What are practical patenting strategies for scientific spin-outs? How can SME participate in the innovation power of start-ups? Jost helps to find answers.
For the European competitiveness, the availability of resources and their efficient use must be secured in the long term. DexLeChem helps to further develop the according EU research framework H2020 in an expert workshop of RECREATE on June, 6.
Prof. John Warner, one of the founding fathers of Green Chemistry and editor of the Open Access and peer-reviewed journal “Green Chemistry Letters and Reviews”, appointed DexLeChem CEO Jost to the editorial board.
During the Next Economy Award 2015 competition DexLeChem was chosen out of 175 applicants as the winner in the category "resources" for its ambitious and promising business model.
DexLeChem is nominated with its new service "Optimize Biotech" for the Innovation Prize of Chemie-Cluster Bayern. The final prize will be awarded in Fürstenfeld at November, 9.
Invited by the Chamber of Commerce DexLeChem participates in a delegation trip to Israel from October 10 to 14. The topics are high interest issues for DexLeChem: how to build high-tech cooperations and innovation partnerships as well as networking among start-ups.
Smart, sustainable and innovative: SMEs have an important impact on the economy in Berlin. As CEO of a high-tech company in chemistry Sonja Jost is invited to discuss the potential of Alliance 4.0 for Berlin and to introduce her company at the House of Representatives on September 17.
During the Ost-West-Wirtschaftsforum Sonja Jost discusses the social and ecological responsibility of entrepreneurs with the German politician Gregor Gysi. Sharing the vision of contributing to the German “Chemiewende” (transition of chemical industry) this is a major issue for DexLeChem.
How does DexLeChem manage its interdisciplinary R&D team so successfully and what is the way to get the most out of their creativity while keeping focussed on project goals? As this question arises very frequently in meetings with our customers we decided to give you some insights into our unique agile project management system.
Sonja Jost, CEO DexLeChem lectures during the first GTEC Open Campus in Germany on July 9 in Berlin. The event is organized by the German Technology Entrepreneurship Center.
Sonja Jost supports the Junior Social Entrepreneurship Summit also in 2015 as a mentor. The Summit is taking place in Berlin (Juli 20 to 24) and Los Angelos. Hosts are the FU Berlin, TU Berlin and the University of Southern California (USC).
Hosted by DexLeChem and the IZBM, the fourth event of Chemistry4Innovation will take place at the CoLaborator on July 17. The talks cover two highly relevant topics: cost-efficient synthesis of organic electronic compounds and the development of earth-abundant and therefore easily accessible catalysts.
How can scientific findings be implemented into industry? During the RESOLV International Women Scientist Meeting at the Ruhr-Universität Bochum Sonja Jost talks about her experience as foundress of a high-tech startup in Chemistry.
German innovations are of high interest for China. In order to get to know new approaches in chemical-pharmaceutical production a delegation of experts from the renowned CASS Institute visits DexLeChem on June 2.
As CEO of a startup for Green Chemistry, Sonja Jost discusses with the governing mayor of Berlin, Michael Müller and leading industry representatives how to strengthen Berlin as industrial location.
New routes of synthesis are increasingly important in view of scarce resources. In fact they are indispensable in order to achieve the German "Chemiewende" (transition of the chemical industry). Our experts in catalysis develop cost-efficient routes of synthesis for noble metal catalysts providing high selectivity and yields.
Hosted by DexLeChem and the IZBM, the third event of Chemistry4Innovation will take place at the CoLaborator on May 29. The talks cover two hot topics: quantum chemical simulations and catalyst re-using techniques.
Once more DexLeChem supports the IMMS initiative of the Berlin Chamber of Commerce. During her talk Sonja Jost shows that building one’s own business is a real opportunity after finishing school and training.
On April 20, representatives of the CDU/CSU parliamentary group at the Bundestag visited DexLeChem. During a tour through the laboratory of DexLeChem CEO Sonja Jost gave new impulses on the sustainable reindustrialization in Germany.
CEO Jost was honored with the Victress Life Science Award 2015 presented by Alex von Frankenberg (HTGF) in front of 800 invited guests. Her work as innovator and foundress of a hightech startup for Green Chemistry, as well as her clear growth oriented vision convinced the jury.
The young company was able to win important representatives as the founder of Green Chemistry Prof. John Warner or Dr. Matthias Braun, Board Member Sanofi-Aventis Germany to participate in the board.
Hosted by DexLeChem and the IZBM, the second event of Chemistry4Innovation will take place at the CoLaborator on March 20. The talks cover two interesting topics: digital labs and latest findings in stereoselective organocatalysis.
DexLeChem is participating in a catalysis workshop on February 26/27 held by Bayer. The exchange of experience with international catalysis experts is of vital importance for a young, innovation-oriented company.
In the last years pharmaceutical companies are increasingly outsourcing part of their business to custom manufacturing organizations (CMOs) in order to reduce cost and to increase flexibility. The field is becoming more and more competitive. This is where the services of DexLeChem step in.
What can be done to optimize processes in chiral catalysis risk-free? Successful risk management and a solid cost estimate require not only an analysis on molecular and experimental basis but a view to the whole.
As recently announced during the UNIDO conference in Vienna, Germany intends to open a Sustainalbe Chemistry Center. This is a clear sign that politics and economy have started to put a stronger focus on Green Chemistry.
A recently published in the CHEManager the success of innovations (return on investment, ROI) is not always clearly measurable. Nevertheless, innovations are an indispensable investment in the future.
The E Factor is used as a tool to evaluate chemical processes regarding resource efficiency and waste management. The novel routes of synthesis designed by DexLeChem make it possible to reduce this factor considerably thus enabling a more sustainable synthesis.
How can chemical leasing contribute to Green Chemistry? As a member in the Chemical Leasing working group DexLeChem supports the model for more sustainability in chemical production. This is precisely what the innovative approach of DexLeChem offers.
Cost-effective and ecological: The globally renowned company LONZA is impressed by the “creativity, smart solutions, speed and outstanding technological know-how" of DexLeChem.
Mario Rückl, Chemie-Cluster Bayern, was visiting DexLeChem on November 14 in order to discuss a possible cooperation. In the meantime R. Pop and N. Ludwig (representatives of Alliance 90/The Greens) were looking for information about the turnaround in chemical industry.
Which are the best strategies to promote the German health industry? Jost and Rahmel, DexLeChem are invited to discuss this issue with Dr. T. Strüngmann, founder of Hexal and Dr. A. Ziegler, CEO Ziegler AG on November 18 on the panel.
Green, scientific spin-outs from research institutes should contribute to the sustainable reindustrialization in Berlin. The governing mayor of Berlin supports this demand of DexLeChem CEO Jost.
Sonja Jost is invited to participate in a workshop for female experts on November 8. As university spin-out and foundress of a high-tech company in green chemistry she gives an insight on her entrepreneurial experience.
